Patents by Inventor J. Schlessinger

J. Schlessinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4933294
    Abstract: Neoplastic and other diseases can be diagnosed by assaying a human test sample e.g. body fluid, tissue or cultured tumor explant cells, for structurally altered or abnormally expressed growth factor receptors or for the RNA transcripts of genes which encode them. For example, the assay can be for truncated EGF receptor having at least a portion of its mature amino terminus deleted. Antibodies, capable of binding a predetermined amino acid sequence within the EGF receptor, are also useful in diagnosis and therapy as are conjugates of an immunogenic polymer bound to a polypeptide fragment of EGF receptor. DNA and RNA encoding EGF receptor or fragments thereof are also described.
    Type: Grant
    Filed: September 30, 1985
    Date of Patent: June 12, 1990
    Assignees: ICRF Patents Limited, Research & Development Co., Ltd. Yeda, Genentech, Inc.
    Inventors: Michael D. Waterfield, J. Schlessinger, Axel Ullrich